share_log
Reuters ·  Jan 7 12:04
Metsera Announces Positive Topline Phase 2a Clinical Data for Its Ultra-Long Acting GLP-1 Receptor Agonist, Met-097I
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment